Have a personal or library account? Click to login
Development of a selective biopharmaceutical from Herpes simplex virus type 1 glycoproteins E and I for blocking antibody mediated neutralization of oncolytic viruses Cover

Development of a selective biopharmaceutical from Herpes simplex virus type 1 glycoproteins E and I for blocking antibody mediated neutralization of oncolytic viruses

Acta Pharmaceutica
Volume 60 (2010): Issue 4 (December 2010)
By: Septimiu Bucurescu  
Open Access
|Dec 2010

Metrics

DOI: https://doi.org/10.2478/v10007-010-0039-2 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 407 - 413
Published on: Dec 17, 2010
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
cancer therapies,
Herpes simplex virus type 1 glycoproteins E and I,
antibody mediated neutralization of oncolytic viruses
Related subjects:
Pharmacy,
Pharmacy, other

© 2010 Septimiu Bucurescu, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 60 (2010): Issue 4 (December 2010)